Severe RSV Before Age 2 Linked to Lasting Lung Changes
Infants who experience severe respiratory syncytial virus infections face increased risk of structural lung changes that could impair their respiratory health into adulthood, research suggests.
Tag: pediatric care
All
Latest
All
Latest
CDC: Nirsevimab 90% Effective Against RSV in Infants
CDC data show that nirsevimab was highly effective in protecting infants from hospitalizations associated with respiratory syncytial virus.
All
Latest
COVID-19 Vaccines in Pregnancy Shield Infants for Six Months
An NIH study found that women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth.
Household Dust Composition Influences Child Asthma and Allergy Rates
The recent study identifies how the chemical composition of household dust, influenced by indoor microorganisms and human activity, varies significantly between homes of children with and without asthma and allergic rhinitis.
Read More
Fewer Asthma Attacks for Black Adults and Children During COVID-19
Relative to Whites, asthma attacks and related emergency department visits trended downward among Black adults and children during the COVID-19 pandemic.
Read More
Omalizumab Reduces Allergic Reactions to Multiple Foods in Youth
The monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume.
Read More
FDA Clears Masimo Stork Baby Monitoring System for Prescription Use
The FDA granted 510(k) clearance to Masimo’s Stork, a baby monitoring system, for prescription use with healthy and sick babies 0-18 months of age.
Read More
Early Lung Development Driven by Immune Cells
The work reveals a “surprising” coordination between the immune and respiratory systems, much earlier in development than previously thought, according to the researchers.
Read More
FDA Approves First CRISPR-based Therapy for Sickle Cell Disease
The FDA approved the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years and older. One therapy, Casgevy, is the first FDA-approved treatment to utilize the genome editing technology CRISPR/Cas9
Read More
Adenotonsillectomy Benefits Kids with Mild Sleep Apnea, Study Shows
Surgical removal of the tonsils and adenoids in children with snoring and mild breathing problems during sleep appears to improve their sleep, quality of life, and blood pressure a year after surgery.
Read More
Sickle Cell Eye Complications Affect Children at Same Rate as Adults
A study of kids with sickle cell disease revealed one-in-three had sickle retinopathy, suggesting children need to be screened for vision problems as often as adults.
Read More
Health Canada OKs Ivacaftor for Cystic Fibrosis Patients Down to 2 Months
Health Canada granted market authorization for the expanded use of ivacaftor to treat cystic fibrosis in certain children ages 2 months and older.
Read More
Maternal COVID-19 Shots Linked to Decrease in Preterm Births
A new study indicates that COVID-19 vaccination during pregnancy significantly reduced preterm births and NICU admissions, which were elevated during the first two years of the pandemic.
Read More
An AI Stethoscope Improves Home Asthma Monitoring in Children
A new study reveals that an AI-aided stethoscope significantly improves the accuracy of home monitoring for asthma symptoms, including in very young children.
Read More
WHO Launches E-course on Pediatric Tuberculosis Management
On World Children’s Day (Nov 20), the World Health Organization launched a new e-course on the management of tuberculosis in children and adolescents.
Read More